ASX
Neuren Pharmaceuticals
NEU:ASX•Healthcare
Sensitive ASX Announcement
DAYBUE Q1 2025 net sales US$84.6m up 11% from Q1 2024
Published: 08/05/25, 09:02am (AEST)•3 pages